Medical device and method for producing the same
A medical device and a method of manufacturing the same which excels in lubricity under severe conditions are provided. The medical device according to the present disclosure is inserted into a living body. The medical device includes a resin coating layer that includes a maleic acid polymer substance and is provided on a surface of a base member. The resin coating layer is formed by covalently bonding the maleic acid polymer substance to a reactive functional group which exists on at least the surface of the base member of the medical device. A ratio of a peak height of carboxylate with respect to a total peak height of carboxylic acid ester and a carboxylic acid in the maleic acid polymer substance ranges from 1.2 to 1.7 when being measured through infrared spectroscopy (IR method).
1. A medical device capable of being inserted into a living body, the medical device comprising:
a resin coating layer that includes a maleic acid polymer substance,
wherein the resin coating layer is provided on a surface of a base member of the medical device,
wherein the resin coating layer is formed by covalently bonding the maleic acid polymer substance to a reactive functional group which exists on at least the surface of the base member of the medical device, and
wherein the maleic acid polymer substance has a ratio of a peak height of carboxylate with respect to a total peak height of carboxylic acid ester and a carboxylic acid in a range from 1.2 to 1.7 when being measured through infrared spectroscopy, and wherein the ratio of a peak height of carboxylate with respect to a total peak height of carboxylic acid ester and a carboxylic acid in the range from 1.2 to 1.7 when being measured through infrared spectroscopy is obtained by subjecting the maleic acid polymer substance to an alkali treatment,
wherein the maleic acid polymer substance includes a constituting unit of formula (a′), a constituting unit of formula (a″), or a combination thereof:
wherein in formulas (a′) and (a″), X represents an alkali metal or an alkaline earth metal, and R represents a straight chain or branched alkyl group of carbon atom numbers 1 to 24.
2. The medical device according to claim 1 , wherein the reactive functional group is an isocyanate group, an amino group, an aldehyde group, or an epoxy group.
3. The medical device according to claim 1 , wherein the maleic acid polymer substance is an alkyl vinyl ether-maleic acid ester copolymer.
4. The medical device according to claim 2 , wherein the maleic acid polymer substance is an alkyl vinyl ether-maleic acid ester copolymer.
5. The medical device according to claim 1 , wherein the maleic acid polymer substance has a ratio of a peak height of carboxylate with respect to a total peak height of carboxylic acid ester and a carboxylic acid in a range from 1.2 to 1.6 when being measured through infrared spectroscopy.
6. The medical device according to claim 1 , wherein the maleic acid polymer substance has a ratio of a peak height of carboxylate with respect to a total peak height of carboxylic acid ester and a carboxylic acid in a range from 1.2 to 1.5 when being measured through infrared spectroscopy.
7. The medical device according to claim 1 , wherein the resin coating layer is formed on at least a surface portion of the medical device which contacts a body fluid or blood.
8. The medical device according to claim 1 , wherein the maleic acid polymer substance includes a constituting unit of formula (a),
wherein in formula (a), R represents a straight chain or branched alkyl group of carbon atom numbers 1 to 24.
9. The medical device according to claim 1 , wherein the maleic acid polymer substance includes the constituting unit of formula (a′) and the constituting unit of formula (a″).
10. The medical device according to claim 1 , wherein a weight-average molecular weight of the maleic acid polymer substance ranges from 10,000 to 7,000,000.
11. The medical device according to claim 1 , wherein a weight-average molecular weight of the maleic acid polymer substance ranges from 100,000 to 5,000,000.
12. The medical device according to claim 1 , wherein the reactive functional group includes a diazonium group, an azide group, an isocyanate group, an acid chloride group, an acid anhydride group, an imino carbonate ester group, an amino group, a carboxyl group, an epoxy group, a hydroxyl group, a peroxide group, an aldehyde group, or a combination thereof.
13. The medical device according to claim 1 , wherein the reactive functional group includes an isocyanate group, an amino group, an aldehyde group, an epoxy group, or a combination thereof.
14. A method of manufacturing the medical device according to claim 1 , the method comprising:
treating a base member of the medical device with a solution including a compound which has a reactive functional group, to form a ground layer in which the reactive functional group exists, on at least a surface of the base member;
treating the ground layer with a maleic acid polymer substance, to covalently bond the reactive functional group and the maleic acid polymer substance to each other and to form a resin coating layer which includes the maleic acid polymer substance, on the ground layer; and
performing an alkali treatment of the base member on which the ground layer and the resin coating layer are formed,
wherein the alkali treatment is performed by dipping the base member on which the ground layer and the resin coating layer are formed, in an alkaline solution having a pH of equal to or greater than 9.5 at a temperature ranging from 25° C. to 70° C. for a period ranging from 0.1 hours to 20 hours.
15. The method according to claim 14 , further comprising:
cleaning the base member after alkali treatment, with a cleaning liquid of which the concentration of calcium is less than 20 mg/L.
16. The method according to claim 15 , wherein the concentration of calcium in the cleaning liquid ranges from 0 mg/L to 10 mg/L.
17. The method according to claim 14 , wherein the alkaline solution having a pH of equal to or greater than 9.5 is aqueous sodium hydroxide.
18. The method according to claim 15 , wherein the alkaline solution having a pH of equal to or greater than 9.5 is aqueous sodium hydroxide.
19. The medical device according to claim 1 , wherein the alkali treatment comprises dipping the maleic acid polymer substance in an alkaline solution of which pH is equal to or greater than 9.5 at a temperature ranging from 25 to 70° C. for a period ranging from 0.1 to 20 hours.
20. The medical device according to claim 1 , wherein X represents lithium, sodium, potassium, rubidium, cesium, magnesium, calcium, strontium, or barium.